ロード中...
Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ Africans
BACKGROUND: Efavirenz is commonly used in Africa and is frequently associated with neurocognitive toxicity, which may compromise clinical outcomes. Older individuals are at increased risk for drug toxicity and clinical outcomes may be worse in older age, particularly among those individuals with cyt...
保存先:
| 出版年: | Eur J Drug Metab Pharmacokinet |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6420397/ https://ncbi.nlm.nih.gov/pubmed/30168000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-018-0507-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|